Page last updated: 2024-09-05

technetium tc 99m pentetate and Graves Disease

technetium tc 99m pentetate has been researched along with Graves Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chen, L; Wang, Y; Wei, L; Yang, J; Zhong, P1
Galuska, L; Garai, I; Leovey, A; Nagy, EV; Szabo, J; Szucs-Farkas, Z; Varga, J1
Boda, J; Galuska, L; Garai, I; Leovey, A; Nagy, EV; Szabo, J; Szucs Farkas, Z; Varga, J1
Galuska, L; Garai, I; Leövey, A; Nagy, E; Szabados, L; Szabó, J; Szúcs-Farkas, Z; Varga, J1
Junik, R1
Balazs, E; Berta, A; Galuska, L; Garai, I; Leovey, A; Nagy, EV; Szabados, L; Szucs-Farkas, Z; Varga, J1
Alevizaki, C; Alevizaki-Harhalaki, M; Georgiou, E; Ikkos, D; Proukauis, C1

Reviews

1 review(s) available for technetium tc 99m pentetate and Graves Disease

ArticleYear
[Nuclear medicine imaging methods in thyroid associated ophthalmopathy].
    Przeglad lekarski, 2004, Volume: 61, Issue:8

    Topics: Citrates; Gallium; Graves Disease; Humans; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Pentetate

2004

Other Studies

6 other study(ies) available for technetium tc 99m pentetate and Graves Disease

ArticleYear
Thyroid Accumulation of 99m Tc-DTPA in Graves Disease.
    Clinical nuclear medicine, 2023, 11-01, Volume: 48, Issue:11

    Topics: Adult; Female; Graves Disease; Humans; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed

2023
SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MRI.
    Nuclear medicine communications, 2002, Volume: 23, Issue:12

    Topics: Adult; Aged; Eye; Female; Graves Disease; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon

2002
Active retrobulbar inflammation in Graves' ophthalmopathy visualized by Tc-99m DTPA SPECT.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:6

    Topics: Graves Disease; Humans; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon

2003
[Assessment of autoimmune disease activity in endocrine orbitopathy: comparison of SPECT using 99m-Tc-DTPA or 99m-Tc-depreotide and MRI scores].
    Orvosi hetilap, 2003, Oct-12, Volume: 144, Issue:41

    Topics: Adult; Female; Graves Disease; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon

2003
Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
    Nuclear medicine communications, 2005, Volume: 26, Issue:5

    Topics: Brain; Female; Graves Disease; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Male; Orbit; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon

2005
Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1983, Volume: 24, Issue:2

    Topics: Female; Graves Disease; Humans; Leg Dermatoses; Male; Middle Aged; Myxedema; Pentetic Acid; Radionuclide Imaging; Technetium; Technetium Tc 99m Pentetate

1983
chemdatabank.com